Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-03 4:05 pm Purchase | 13G | HARPOON THERAPEUTICS INC N HARP | COMMODORE CAPITAL LP | 1,703,465 9.9% | 1,703,465 (New Position) | View |
| 2023-10-27 4:05 pm Purchase | 13G | NKARTA INC NKTX | COMMODORE CAPITAL LP | 2,730,000 5.6% | 2,730,000 (New Position) | View |
| 2023-10-16 4:05 pm Purchase | 13G | SAB BIOTHERAPEUTICS INC SABS | COMMODORE CAPITAL LP | 6,932,463 9.9% | 6,932,463 (New Position) | View |
| 2023-10-12 4:05 pm Purchase | 13G | SOLENO THERAPEUTICS INC PA SLNO | COMMODORE CAPITAL LP | 885,741 6% | 885,741 (New Position) | View |
| 2023-10-06 4:05 pm Purchase | 13G | VISTAGEN THERAPEUTICS INC VTGN | COMMODORE CAPITAL LP | 2,367,884 9.9% | 792,884 (+50.34%) | View |
| 2023-08-09 4:15 pm Purchase | 13G | VISTAGEN THERAPEUTICS INC VTGN | COMMODORE CAPITAL LP | 1,575,000 19.7% | 1,575,000 (New Position) | View |
| 2023-04-27 4:05 pm Sale | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | COMMODORE CAPITAL LP | 31,181,983 8.1% | -4,518,017 (-12.66%) | View |
| 2023-04-24 4:05 pm Purchase | 13G | ENLIVEN THERAPEUTICS INC ELVN | COMMODORE CAPITAL LP | 2,082,123 5.1% | 633,483 (+43.73%) | View |
| 2023-04-20 4:05 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | COMMODORE CAPITAL LP | 6,158,141 6.1% | 6,158,141 (New Position) | View |
| 2023-03-30 4:05 pm Purchase | 13G | BELLUS HEALTH INC BLU | COMMODORE CAPITAL LP | 6,579,359 5.2% | 1,275,802 (+24.06%) | View |
| 2023-03-03 4:10 pm Purchase | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | COMMODORE CAPITAL LP | 35,700,000 13.2% | 9,450,000 (+36.00%) | View |
| 2023-03-03 4:05 pm Purchase | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | COMMODORE CAPITAL LP | 26,250,000 9.7% | 26,250,000 (New Position) | View |
| 2023-02-28 4:05 pm Purchase | 13G | ENLIVEN THERAPEUTICS INC ELVN | COMMODORE CAPITAL LP | 1,448,640 3.5% | 1,448,640 (New Position) | View |
| 2023-02-21 4:05 pm Purchase | 13G | IMARA INC IMRA | COMMODORE CAPITAL LP | 2,840,754 10.8% | 345,960 (+13.87%) | View |
| 2023-02-16 4:05 pm Purchase | 13G | VERA THERAPEUTICS INC VERA | COMMODORE CAPITAL LP | 2,342,857 5.6% | 2,342,857 (New Position) | View |
| 2023-02-14 4:06 pm Purchase | 13G | IMARA INC IMRA | COMMODORE CAPITAL LP | 2,494,794 9.5% | 996,884 (+66.55%) | View |
| 2023-02-14 4:06 pm Sale | 13G | KARYOPHARM THERAPEUTICS INC KPTI | COMMODORE CAPITAL LP | 1,935,609 1.7% | -2,075,443 (-51.74%) | View |
| 2023-02-14 4:06 pm Sale | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | COMMODORE CAPITAL LP | 0 0% | -10,455,910 (Position Closed) | View |
| 2023-02-14 4:06 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | COMMODORE CAPITAL LP | 2,020,166 5% | 648,827 (+47.31%) | View |
| 2023-02-14 4:06 pm Sale | 13G | BELLUS HEALTH INC BLU | COMMODORE CAPITAL LP | 5,303,557 4.2% | -153,553 (-2.81%) | View |